# Colossa Ventures

> Colossa Ventures is a VC fund backing Health Care, Fashion and Computer. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 11
- Last investment: Apr 2026
- Lead investor: 64%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/colossa-ventures/

Colossa Ventures is an ecosystem of investments with the goal of empowering India's women's economy one business at a time. They are here to invest in "women first" enterprises that are upending the current quo and influencing the future through the power of the 3 Cs: capital, capability, and confidence.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $119k–$6M |
| Series A | $2.3M–$5M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 18% |
| Fashion | 1 | 9% |
| Computer | 1 | 9% |
| Internet | 1 | 9% |
| Education | 1 | 9% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 45% |
| Series A | 3 | 27% |
| Series B | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Morphing Machines | Morphing Machines is on a mission to create an exciting new range of silicon-centric solutions for compute-intensive applications. Leveraging the path-breaking patent-pending REDEFINE Reconfigurable Massively Parallel Processor SoC platform technology, a variety of high-performance silicon solutions for various application domains have beendeveloped at Morphing Machines in the areas of cryptography, data security, avionics, high-definition image and video processing, numerical computation, neural networks and deep learning, and other areas.REDEFINE based solutions deliver a unique combination of high performance and flexibility not available from other technologies offered by global players. REDEFINE technology enables ASIC-like high performance at an affordable NRE cost for a much wider range of compute-intensive applications than has ever been possible before. Advanced compiler toolchain and runtime software support is an integral part of the REDEFINE offerings. | $4.5M | Series A | Apr 27, 2026 |  |
| FinReach | FinReach Solutions is a company providing innovative credit guarantee programs to facilitate lending for underserved micro, small, and medium enterprises (MSMEs), particularly those lacking collateral or formal credit history. Their solution enables financial institutions to extend credit to entrepreneurs, including women-led businesses andclimate-focused ventures, by de-risking loans through guarantees and leveraging data-driven borrower risk assessment. FinReach aims to expand financial inclusion in India’s lower-tier regions, helping thousands of borrowers access formal finance through partnerships with development finance institutions and global impact investors. | $2.5M | Seed | Nov 24, 2025 |  |
| FS Life | FS Life is a House of Brands offering apparel and lifestyle needs for modern Indian women. Ayushi Gudwani launched FableStreet in 2016 as a premium workwear brand. As the epidemic spread and workwear lost its relevance as a category, there was a significant product overhaul and growth, and the company changed into a multi-category western wearbrand that featured not just workwear but also evening clothing, day wear, etc. FableStreet's extraordinary success led to the creation of two additional brands: Mikoto, a sterling silver and semi-precious jewelry brand that offers high-quality jewelry at affordable prices, and Marigold, a modern Indian wear brand that reimagines traditional clothing for today's women.FableStreet changed from being a single brand to a House of Brands under the banner of "FS Life" in July 2022. As a company, they will concentrate on creating a collection of domestic D2C lifestyle brands that are thoughtful, current, and address unmet apparel and lifestyle demands for the contemporary Indian lady in the mass-premium to premium sector. | $5.6M | Series B | Oct 10, 2025 |  |
| Meolaa | The Meolaa platform will be powered by an innovative, experience-driven approach that will bridge the gap between sustainability and lifestyle. | $6M | Seed | Oct 08, 2025 |  |
| Exposome | Exposome cutting-edge solutions help deliver cleaner air and water from various industrial streams such as Chemical Manufacturing | $2.6M | Seed | Sep 29, 2025 |  |
| CENTA | CENTA is an accreditation, job, and development organization for teachers and school leaders. They offer resources, certification, learning, and teaching services. Their services connect them to career opportunities and provide development assistance. | $2.3M | Series A | Apr 15, 2025 |  |
| Ahammune Biosciences | Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. | $5M | Series A | Sep 25, 2024 |  |
| Exposome | Exposome cutting-edge solutions help deliver cleaner air and water from various industrial streams such as Chemical Manufacturing | $1.2M | Seed | Sep 10, 2024 |  |
| Serigen Mediproducts | Serigen Mediproducts Private Limited is an unlisted private company incorporated on 03 February, 2015. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 2.00 lac and the total paid-up capital is INR 1.52 lac. | $119.2K | Seed | Aug 29, 2024 |  |
| Serigen Mediproducts | Serigen Mediproducts Private Limited is an unlisted private company incorporated on 03 February, 2015. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 2.00 lac and the total paid-up capital is INR 1.52 lac. | $705.1K | Seed | Mar 29, 2023 |  |

10 of 11 investments shown.

## Co-investors
- [Excel Industries](https://shizune.co/investors/profile/excel-industries) — VC Fund, 2 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 2 deals together
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund, 2 deals together
- [Spectrum Impact](https://shizune.co/investors/profile/spectrum-impact) — VC Fund, 2 deals together
- [3i Partners](https://shizune.co/investors/profile/3i-partners) — VC Fund, 1 deal together
- [Bhukhanvala Holdings](https://shizune.co/investors/profile/bhukhanvala-holdings) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Titan Capital](https://shizune.co/investors/profile/titan-capital) — VC Fund
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund
- [Blume Ventures](https://shizune.co/investors/profile/blume-ventures) — VC Fund

## Featured in investor lists
- [Life Science Investors in India](https://shizune.co/investors/life-science-investors-india)
- [Life Science VC Funds in India](https://shizune.co/investors/life-science-vc-funds-india)
- [Biotechnology VC Funds in India](https://shizune.co/investors/biotechnology-vc-funds-india)
- [Biotech VC Funds in India](https://shizune.co/investors/biotech-vc-funds-india)

## FAQ

### What does Colossa Ventures invest in?

Colossa Ventures invests primarily in Health Care, Fashion and Computer startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Colossa Ventures's check size?

Colossa Ventures typically joins rounds of $119k–$6M at Seed and $2.3M–$5M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Colossa Ventures participates in.

### When did Colossa Ventures last invest?

The most recent investment recorded for Colossa Ventures closed in Apr 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co